HilleVax (HLVX) News Today $1.89 -0.01 (-0.53%) (As of 05:20 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Cautious Hold Rating on HilleVax, Inc: Balancing Strong Cash Reserves with Strategic UncertaintyNovember 12 at 6:43 AM | markets.businessinsider.comHilleVax Reports Q3 Financial Results Amid Strategic PlanningNovember 9, 2024 | markets.businessinsider.comHilleVax, Inc: Analyst Maintains Hold Rating Amid Vaccine Trial Setback and Strategic ShiftNovember 9, 2024 | markets.businessinsider.comHilleVax (NASDAQ:HLVX) Shares Down 1.5% Following Weak EarningsNovember 9, 2024 | americanbankingnews.comHilleVax (NASDAQ:HLVX) Stock Price Down 1.5% on Disappointing EarningsHilleVax (NASDAQ:HLVX) Stock Price Down 1.5% After Earnings MissNovember 9, 2024 | marketbeat.comHilleVax, Inc. (NASDAQ:HLVX) Receives Consensus Recommendation of "Hold" from BrokeragesHilleVax, Inc. (NASDAQ:HLVX - Get Free Report) has received an average rating of "Hold" from the six brokerages that are covering the firm, MarketBeat reports. Six equities research analysts have rated the stock with a hold recommendation. The average 1 year target price among analysts that have iOctober 18, 2024 | marketbeat.comTrium Capital LLP Acquires New Shares in HilleVax, Inc. (NASDAQ:HLVX)Trium Capital LLP bought a new position in HilleVax, Inc. (NASDAQ:HLVX - Free Report) in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund bought 453,260 shares of the company's stock, valued at approximately $798,000. Trium Capital LLP ownOctober 8, 2024 | marketbeat.comPoint72 Asset Management L.P. Makes New $6.96 Million Investment in HilleVax, Inc. (NASDAQ:HLVX)Point72 Asset Management L.P. bought a new stake in HilleVax, Inc. (NASDAQ:HLVX - Free Report) during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The firm bought 481,312 shares of the company's stock, valued at approximately $6,960,000. Point72 Asset Management L.P.October 2, 2024 | marketbeat.comFrazier Life Sciences Management L.P. Has $153.52 Million Holdings in HilleVax, Inc. (NASDAQ:HLVX)Frazier Life Sciences Management L.P. grew its holdings in shares of HilleVax, Inc. (NASDAQ:HLVX - Free Report) by 8.5% in the 2nd quarter, according to its most recent disclosure with the SEC. The fund owned 10,617,062 shares of the company's stock after acquiring an additional 835,590 shares duriSeptember 29, 2024 | marketbeat.comHilleVax, Inc. (NASDAQ:HLVX) Given Average Rating of "Hold" by AnalystsHilleVax, Inc. (NASDAQ:HLVX - Get Free Report) has been assigned a consensus recommendation of "Hold" from the six research firms that are presently covering the firm, MarketBeat.com reports. Six investment analysts have rated the stock with a hold rating. The average 12-month target price among bAugust 29, 2024 | marketbeat.comAVXL Aug 2024 12.500 put (AVXL240823P00012500)August 19, 2024 | finance.yahoo.comHilleVax, Inc. (NASDAQ:HLVX) Short Interest UpdateHilleVax, Inc. (NASDAQ:HLVX - Get Free Report) was the recipient of a large increase in short interest during the month of July. As of July 31st, there was short interest totalling 1,620,000 shares, an increase of 32.8% from the July 15th total of 1,220,000 shares. Based on an average trading volume of 1,030,000 shares, the days-to-cover ratio is presently 1.6 days. Currently, 9.7% of the company's shares are sold short.August 15, 2024 | marketbeat.comQ3 2024 Earnings Forecast for HilleVax, Inc. (NASDAQ:HLVX) Issued By HC WainwrightHilleVax, Inc. (NASDAQ:HLVX - Free Report) - Equities research analysts at HC Wainwright increased their Q3 2024 EPS estimates for HilleVax in a research note issued to investors on Monday, August 12th. HC Wainwright analyst M. Caufield now forecasts that the company will post earnings per shareAugust 15, 2024 | marketbeat.comHilleVax, Inc.: Prudent Cost Management Amidst Trial Setbacks – Hold Rating JustifiedAugust 14, 2024 | markets.businessinsider.comHilleVax, Inc: Hold Rating Amid Vaccine Efficacy Concerns and Financial UncertaintyAugust 12, 2024 | markets.businessinsider.comLumen to build 'critical infrastructure for decades': CEOAugust 9, 2024 | uk.finance.yahoo.comMortgage rates fall to lowest level in a year. What it meansAugust 9, 2024 | uk.finance.yahoo.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HilleVax, Inc. - HLVXAugust 9, 2024 | prnewswire.comHilleVax Reports Second Quarter 2024 Financial Results and Highlights Recent Company ProgressAugust 8, 2024 | globenewswire.comHilleVax, Inc. (HLVX) stock historical prices & data – Yahoo FinanceAugust 8, 2024 | nz.finance.yahoo.comHilleVax, Inc. (NASDAQ:HLVX) Given Consensus Recommendation of "Hold" by BrokeragesShares of HilleVax, Inc. (NASDAQ:HLVX - Get Free Report) have been given an average recommendation of "Hold" by the six analysts that are presently covering the company, MarketBeat.com reports. Six analysts have rated the stock with a hold rating. The average twelve-month price target among brokerAugust 4, 2024 | marketbeat.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HilleVax, Inc. - HLVXAugust 3, 2024 | globenewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HilleVax, Inc. - HLVXAugust 1, 2024 | prnewswire.comBoston biotech behind norovirus vaccine cuts 40% of workforceAugust 1, 2024 | bizjournals.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HilleVax, Inc. - HLVXJuly 26, 2024 | globenewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HilleVax, Inc. - HLVXJuly 24, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HilleVax, Inc. - HLVXJuly 20, 2024 | globenewswire.comHilleVax, Inc. (HLVX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged WrongdoingsJuly 19, 2024 | globenewswire.comHilleVax, Inc. (NASDAQ:HLVX) Short Interest Up 7.7% in JuneHilleVax, Inc. (NASDAQ:HLVX - Get Free Report) saw a significant increase in short interest during the month of June. As of June 30th, there was short interest totalling 1,670,000 shares, an increase of 7.7% from the June 15th total of 1,550,000 shares. Approximately 10.0% of the company's shares are short sold. Based on an average trading volume of 730,500 shares, the days-to-cover ratio is currently 2.3 days.July 18, 2024 | marketbeat.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HilleVax, Inc. - HLVXJuly 18, 2024 | prnewswire.comHilleVax, Inc. (HLVX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged WrongdoingsJuly 14, 2024 | globenewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HilleVax, Inc. - HLVXJuly 12, 2024 | globenewswire.comQ3 2024 Earnings Estimate for HilleVax, Inc. Issued By HC Wainwright (NASDAQ:HLVX)HilleVax, Inc. (NASDAQ:HLVX - Free Report) - Investment analysts at HC Wainwright upped their Q3 2024 earnings per share estimates for shares of HilleVax in a research report issued to clients and investors on Tuesday, July 9th. HC Wainwright analyst M. Caufield now forecasts that the company wilJuly 11, 2024 | marketbeat.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HilleVax, Inc. - HLVXJuly 10, 2024 | prnewswire.comLeerink Partnrs Lowers HilleVax (NASDAQ:HLVX) to HoldLeerink Partnrs cut HilleVax from a "strong-buy" rating to a "hold" rating in a report on Tuesday.July 10, 2024 | marketbeat.comHilleVax, Inc. (HLVX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged WrongdoingsJuly 9, 2024 | globenewswire.comWhy Is HilleVax (HLVX) Stock Down 87% Today?July 8, 2024 | investorplace.comHilleVax (NASDAQ:HLVX) Receives Neutral Rating from JPMorgan Chase & Co.JPMorgan Chase & Co. restated a "neutral" rating and set a $5.00 price objective (down previously from $24.00) on shares of HilleVax in a research report on Monday.July 8, 2024 | marketbeat.comHilleVax Reports Topline Data from NEST-IN1 Phase 2b Clinical Study of HIL-214 in InfantsJuly 8, 2024 | globenewswire.comHilleVax (NASDAQ:HLVX) Trading 3.9% Higher HilleVax (NASDAQ:HLVX) Trading Up 3.9%July 2, 2024 | marketbeat.comHilleVax, Inc. (NASDAQ:HLVX) Sees Significant Increase in Short InterestHilleVax, Inc. (NASDAQ:HLVX - Get Free Report) was the recipient of a large growth in short interest in the month of June. As of June 15th, there was short interest totalling 1,550,000 shares, a growth of 14.8% from the May 31st total of 1,350,000 shares. Based on an average daily volume of 177,600 shares, the short-interest ratio is currently 8.7 days. Approximately 9.3% of the company's shares are short sold.July 1, 2024 | marketbeat.comHilleVax (NASDAQ:HLVX) Trading 6.4% Higher HilleVax (NASDAQ:HLVX) Stock Price Up 6.4%June 24, 2024 | marketbeat.comHilleVax (NASDAQ:HLVX) Shares Down 2.9% HilleVax (NASDAQ:HLVX) Stock Price Down 2.9%June 18, 2024 | marketbeat.comHilleVax (NASDAQ:HLVX) Trading Down 3.6%HilleVax (NASDAQ:HLVX) Shares Down 3.6%June 12, 2024 | marketbeat.comBraidwell LP Has $3.27 Million Position in HilleVax, Inc. (NASDAQ:HLVX)Braidwell LP lessened its holdings in HilleVax, Inc. (NASDAQ:HLVX - Free Report) by 86.0% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 203,407 shares of the company's stock after selling 1,245,839 shaJune 12, 2024 | marketbeat.comHilleVax (NASDAQ:HLVX) Trading Up 7.1%HilleVax (NASDAQ:HLVX) Stock Price Up 7.1%June 11, 2024 | marketbeat.com1,308,974 Shares in HilleVax, Inc. (NASDAQ:HLVX) Acquired by Catalys Pacific LLCCatalys Pacific LLC acquired a new position in HilleVax, Inc. (NASDAQ:HLVX - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund acquired 1,308,974 shares of the company's stock, valued at approximately $21,009,000. HilleVax comprises approJune 9, 2024 | marketbeat.comHilleVax (NASDAQ:HLVX) Trading 10% Higher HilleVax (NASDAQ:HLVX) Trading Up 10%June 4, 2024 | marketbeat.comFranklin Resources Inc. Has $29.64 Million Position in HilleVax, Inc. (NASDAQ:HLVX)Franklin Resources Inc. increased its position in HilleVax, Inc. (NASDAQ:HLVX - Free Report) by 4.1% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,846,396 shares of the company's stock after purchasMay 27, 2024 | marketbeat.comHilleVax, Inc. (NASDAQ:HLVX) Director Aditya Kohli Sells 6,000 SharesMay 23, 2024 | insidertrades.com Get HilleVax News Delivered to You Automatically Sign up to receive the latest news and ratings for HLVX and its competitors with MarketBeat's FREE daily newsletter. Email Address Elon Musk has put himself in their crosshairs (Ad)Today, I have another controversial prediction. One which I will take no pleasure in seeing come true. See, even with President Trump returning as the leader of our free country, I believe Elon Musk is in mortal danger. I share with you in this special investigative documentary. HLVX Media Mentions By Week HLVX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HLVX News Sentiment▼-0.370.54▲Average Medical News Sentiment HLVX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HLVX Articles This Week▼92▲HLVX Articles Average Week Get HilleVax News Delivered to You Automatically Sign up to receive the latest news and ratings for HLVX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies JSPR News Today STRO News Today ENGN News Today ITOS News Today ARTV News Today TSHA News Today TCRX News Today PSTX News Today ZURA News Today OCGN News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:HLVX) was last updated on 11/14/2024 by MarketBeat.com Staff From Our PartnersBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredTrump’s Back, but DC’s Coming for Your Money!Trump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThis small cap’s electric marine powertrain broke the world speed recordThe future of marine propulsion has arrived-powered by a $2 billion powerhouse. In collaboration with McLar...The Tomorrow Investor | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | SponsoredThe next assassination attempt won’t be on TrumpPresident Trump is soon to be back in the White House. Unity has been restored to the U.S. But if you wa...Porter & Company | SponsoredElon Musk’s $30 Billion Trump Bet Pays Off—What’s Next?Elon Musk bet big on Trump's victory, and that gamble has already added over $30 billion to his net worth in a...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding HilleVax, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share HilleVax With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
